We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

eXludus Joins BioIT Alliance to Speed Life Sciences Research on Clusters and Grids

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

eXludus Technologies has announced that it has joined the BioIT Alliance, a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine.

"eXludus will contribute leadership in accelerating time-to-discovery through more efficient processing of biomedical applications and data across clusters and Grids, which are today's mainstream computing environments," said Dr. Stephen Perrenod, eXludus's vice president of worldwide sales and marketing. "We are excited about collaborating with the other leading solution providers who are members of the BioIT Alliance."

Rudy Potenzone , BioIT Alliance Manager and Industry Technology Strategist for Pharmaceuticals, said, "We welcome eXludus and their expertise to the best-in-class companies  that make up the BioIT Alliance. The company's Grid Optimizer software can substantially increase throughput in clusters and Grids running workloads with tens, hundreds or thousands of concurrent user jobs. Faster throughput directly contributes to the BioIT Alliance's goal of accelerating scientific discovery."